Does Alzheimer's Cure Matter if We Don't Fix the Economic Infrastructure of the Disease?

David Moss, CFO of INmune Bio shares how the economic burden of Alzheimer’s treatments overshadow any progress in research development.

Related Keywords

United States ,Americans ,Inmune Bio ,David Moss , ,Does Alzheimer ,Cure Matter ,Dont Fix ,Economic Infrastructure ,